Evidence for biliary excretion of vancomycin into stool during intravenous therapy: Potential implications for rectal colonization with vancomycin-resistant enterococci

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4427-4429

  Currie, Brian P ^a,b   Lemos Filho, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BILIARY EXCRETION; CLINICAL ARTICLE; COLON FLORA; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FECES LEVEL; ENTEROCOCCUS; FECES; HUMAN; IMMUNOASSAY; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BILE; CARBON-OXYGEN LIGASES; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; ENTEROCOCCUS; FECES; FLUORESCENCE POLARIZATION IMMUNOASSAY; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INJECTIONS, INTRAVENOUS; RECTUM; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 7244260429     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4427-4429.2004     Document Type: Article

References (15)

1. Bonten, M. J., M. K. Hayden, C. Nathan, et al. 1996. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348:1615-1619.
2. Carmeli, Y., M. H. Samore, and C. Huskins. 1999. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci. Arch. Intern. Med. 159:2461-2468.
3. Centers for Disease Control. 1993. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morb. Mortal. Wkly. Rep. 42:597-599.
4. Currie, B. P., S. Gnass, and M. H. Levi. 1996. A hospital-based rectal swab culture survey to detect vancomycin-resistant enterococci: utility and application. Int. J. Infect. Dis. 1:87-91.
5. Donskey, C. J., T. K. Chowdhry, M. T. Hecker, et al. 2000. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343:1925-1932.
6. Donskey, C. J., T. A. Hanrahan, R. A. Hutton, and L. B. Rice. 1999. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J. Infect Dis. 180:384-390.
7. Geraci, J. E., D. R. Nichols, W. E. Wellinan, and G. T. Ross. 1956. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Mayo Clin. Proc. 31:564-582.
8. Harbarth, S., S. Cosgrove, and Y. Carmeli. 2002. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 46:1619-1628.
9. Lee, C., R. C. Andersen, and K. K. Chen. 1957. Vancomycin, a new antibiotic. V. Distribution, excretion, and renal clearance, p. 82-89. In Antibiotics annual 1956-1957. Medical Encyclopedia, Inc., New York, N.Y.
10. Moellering, R. C., Jr. 1984. Pharmacokinetics of vancomycin. J. Antimicrob. Chemother. 14(Suppl. D):43-52.
11. Morris, J.G., D. K. Shay, J. N. Hebden, et al. 1995. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann. Int. Med. 123:250-259.
12. Murray, B. E. 1995. Editorial response: what can we do about vancomycin-resistant enterococci? Clin. Infect. Dis. 20:1134-1136.
13. Ostrowsky, B. E., L. Venkataraman, E. M. D'Agata, H. S. Gold, P. C. DeGirolami, and M. H. Samore. 1999. Vancomycin-resistant enterococci in intensive care units. Arch. Intern. Med. 159:1467-1472.
14. Tornieporth, N. G., R. B. Roberts, J. John, A. Holher, and L. W. Riley. 1996. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin. Infect. Dis. 23:767-772.
15. Woodford, N. 1998. Glycopeptide-resistant enterococci: a decade of experience. J. Med. Microbiol. 47:849-862.